Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 22:00:00
22nd Century Rg (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
6,43 13,01 0,74 677 401
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.02.2026
Popis společnosti
Obecné informace
Název společnosti22nd Century Group Inc
TickerXXII
Kmenové akcie:Ordinary Shares
RICXXII.O
ISIN-
Prioritní akcieConv. Pref. Shrs
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 56
Akcie v oběhu k 26.01.2026 510 177
MěnaUSD
Kontaktní informace
Ulice8560 Main St Ste 4
MěstoWILLIAMSVILLE
PSČ14221-7435
ZeměUnited States
Kontatní osobaMatt Kreps
Funkce kontaktní osobyInvestor Relations
Telefon17 162 701 523
Fax17168773064
Kontatní telefon12 145 978 200

Business Summary: 22nd Century Group, Inc. is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The Company manufactures and distributes combustible tobacco products containing minimally or non-addictive levels of nicotine. Additionally, the Company provides turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. The Company's product, VLN cigarette has 95% less nicotine than the traditional cigarette. The Company operates through a single segment named Tobacco. It is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. It is also engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, 22nd Century Group Inc revenues decreased 31% to $14.1M. Net loss applicable to common stockholders excluding extraordinary items decreased 46% to $10.3M. Revenues reflect Filtered Cigars segment decrease of 25% to $3.7M, Cigarillos segment decrease of 88% to $89K. Lower net loss reflects United States segment loss decrease of 11% to $8.8M.
Odvětvová klasifikace
TRBC2009Biotechnology / Medical Research
TRBC2012Cigars & Cigarette Manufacturing
RBSS2004Investment Trusts
MGINDUSTRYTobacco
MGSECTORConsumer/Non-Cyclical
NAICSTobacco Manufacturing
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICSCigarette Manufacturing
NAICSResearch and Development in Biotechnology
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICSMedicinal and Botanical Manufacturing
NAICSOffices of Other Holding Companies
NAICS2007Research and Development in Biotechnology
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
SICCigarettes
SICCommercial Physical Research
SICCigarettes
SICHolding Companies, Nec



  • Poslední aktualizace: 14.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerLawrence Firestone6728.11.202328.11.2023
Chief Financial OfficerDaniel Otto3606.04.202406.04.2024
Executive Vice President - Sales and MarketingRobert Manfredonia60
Vice President - Manufacturing OperationsScott Marion-
General Counsel, Corporate SecretaryJonathan Staffeldt4306.04.202406.04.2024